Introduction
Preeclampsia (PE) is a complex inflammatory disorder that occurs in 5-7% of pregnancies (1) , and may have severe outcome for both mother and child. The clinical manifestation of PE is onset of proteinuria and elevated blood pressure in the latter half of the pregnancy. It is generally agreed that the initial stage of PE involves improper placental development in early pregnancy (2) . During placenta development, fetal extravillous trophoblasts invade the maternal uterine wall and help transform the uterine spiral arteries into wide, low-resistant arteries to ensure sufficient blood flow to the placenta (2) . In preeclamptic pregnancies, trophoblast invasion is reduced and the spiral arteries are not properly remodeled, resulting in a shallow placenta. As the fetus grows and requires a fully functional placenta, the insufficient preeclamptic placenta releases increasing amounts of stress signals to the maternal circulation, eventually leading to systemic inflammation with endothelial dysfunction and the clinical signs of PE in the mother (3).
The fetal extravillous trophoblasts invading the maternal uterine wall are foreign to the maternal immune cells, and to ensure a proper immune balance at the feto-maternal interaction site, extravillous trophoblasts express a specialized set of major histocompatibility complex molecules, including human leukocyte antigen (HLA)-G class Ib (4) .
Although the definite functional role has not been established (5) , HLA-G expressed by extravillous trophoblasts is involved in optimal trophoblast invasion and spiral artery remodeling, and reduced or aberrant HLA-G expression has been linked to development of PE (6) . Recent studies have indicated that the 14 base pair (bp) insertion/deletion (I/D) polymorphism (rs66554220) in the 3-untranslated region of exon 8 of the HLA-G gene affects HLA-G transcription (7) . This leads to abnormal or decreased HLA-G protein expression and may result in pathological pregnancies (7) .
Although the genetic mechanisms underlying susceptibility to PE remain unclear, it has been shown that family history increases the risk and that both maternal and paternal/fetal genes contribute to disease development (8, 9) . The importance of addressing the genetic contribution of all family triad members is particularly obvious for investigating a role for HLA-G, which function is mainly assigned to fetal trophoblasts. The HLA-G 14bp I/D polymorphism is considered a candidate for PE risk; however, some studies have reported a positive association to PE for both fetal (10) (11) (12) and maternal HLA-G 14bp I/D genotypes (13) (14) (15) , while others have shown no association to PE in either family triad member (16) (17) (18) (19) (20) (21) . The inconsistency of results may be attributed to insufficient statistical power due to small sample size. Meta-analysis is a powerful approach that pools results of independent analyses and can increase statistical power and resolution. Given the conflicting findings in literature, we conducted a meta-analysis of all available data on the HLA-G 14bp I/D gene polymorphism in relation to PE risk to investigate a possible genetic association in all members of the family triad. We tested robustness of this association with sensitivity analysis. We also sought to determine the variables that potentially alter this association with modifier analysis using subgroups. Figure 1 outlines the strategy used for literature search following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines (22) . Using the terms, "HLA-G polymorphism", "preeclampsia" and "human leukocyte antigen", we searched MEDLINE using PubMed, EMBASE and Science Direct for association studies in English as of April 8th, 2015. Studies were eligible if they had genotype data with a case-control design addressing PE. The literature search yielded 91 citations, which were subjected to screening and a series of exclusions, resulting in 11 articles for inclusion in the meta-analysis as listed in Table 1 (10, 11, (13) (14) (15) (16) (17) (18) (19) (20) (21) . Of the 11 included articles, five (11, 14, 16, 20, 21) presented data either for offspring or mother only. However, Vianna et al's maternal data from European and African cohorts were considered as two studies (20) . Three articles (10, 18, 19) had data for mother and offspring, thus were considered six studies. Data in three articles (13, 15, 17) were for the family triads (offspring, mother and father) and were considered as nine studies. Thus the total number of studies in our meta-analysis was nine studies on offspring (10, 11, 13, (15) (16) (17) (18) (19) 21) , ten studies on mothers (from nine articles) (10, 11, (13) (14) (15) (17) (18) (19) (20) and three studies on fathers (13, 15, 17) .
Materials and methods

Selection of studies
Data extraction
Two investigators independently extracted data and reached consensus on all items. The following information was obtained from each publication: first author's name, publishing year, country of origin, and HLA-G 14bp I/D genotype data of cases and controls. We also calculated frequencies of the variant allele as well as deviations of controls from the Hardy-Weinberg Equilibrium (HWE).
Quality assessment of the studies Quality of the studies was evaluated with use of the Newcastle-Ottawa Scale (23) . Each study was assessed based on three broad perspectives: selection, comparability, and exposure with a score ranging from 0 to 9. Study quality scores for high, medium and poor were ≥7, 4-6 and <4, respectively.
Meta-analysis
Risks of PE for the HLA-G 14bp I/D polymorphism were estimated for each study with odds ratio To compare effects on the same baseline, raw data for genotype frequencies were used to calculate study-specific estimates. Pooled ORs were obtained using either the fixed (24) (in the absence of heterogeneity) or random (25) (in its presence) effects models. Heterogeneity between studies was estimated using the c 2 -based Q test (26) and quantified with the I 2 statistic which measures degree of inconsistency among studies (27) . Given the low power of this test (28) , significance threshold was set at P = 0.10 (28). Sources of heterogeneity were examined with subgroup analysis (27) . The two subgroups examined were: (i) Primipara pregnancies with four offspring studies (13, 16, 18, 19) and four studies on mothers (13, (18) (19) (20) , and (ii) European Caucasians with four offspring studies (11, 13, 16, 18) and three studies on mothers (13, 18, 20) . Sensitivity analysis involving omission of one study at a time and recalculating the pooled OR was used to test for robustness of the summary effects. Data were analyzed using Review 
Results
Characteristics of the studies Table 1 summarizes features of the 11 articles included in the meta-analysis. Four and seven studies were population and hospital-based, respectively. Five of the 11 were matched case-control studies.
The Newcastle-Ottawa Scale indicated the following features of the component studies: (i) methodological quality was variable due to the wide range of scores from 3 to 9; (ii) there were more articles of medium quality (n = 6 at score 4-6) than of high quality (n = 4 at score 7-9); and (iii) the mean (6.3 ±1.9) indicated an overall moderate quality of the studies.
Studies in the meta-analysis were categorized according to the family triad; offspring (552 cases/860 controls), mother (831 cases/1,085 controls) and father (242 cases/200 controls) ( Table 2) . Table 2 shows frequency of the minor allele which was generally II (+/+) in all studies, except Lin et al (19) , Humphrey et al (17) and Quach et al (21) , where DD (-/-) seemed to be the minor allele. All control subjects showed expected HWE, except for the offspring data of Zhang et al. (15) and mother data of Jahan et al (14) . Subgroup analysis of primipara pregnancies for offspring (156 cases/218 controls) and mothers (239 cases/361 controls) in Table 3 showed expected HWE and that the minor allele was II (+/+) in all groups.
Meta-analysis of risk associations for the HLA-G 14bp I/D polymorphism and PE Table 4 of the offspring subgroup analyses came from the Bermingham et al study (16) .
Heterogeneity Table 4 shows that of the 12 overall comparisons, all four offspring effects (33%) were heterogeneous (I 2 = 50-62%), all in the offspring group. Zero heterogeneity (I 2 = 0%) was observed in three of the four mother effects and in all father effects. Of the offspring subgroup comparisons in Table 5 , two of the eight effects were heterogeneous (I 2 = 64-66%).
Sensitivity analysis
We used sensitivity treatment to explore change in direction of association (increased or decreased risk for PE) and whether non-significant effects became significant resulting from serial omission of included studies (Table 6 ). In subgroup analysis of offspring HLA-G 14bp I/D genotypes, removal of
Bermingham et al (16) that had the lowest NOS (Table 1) and Hylenius et al (13) resulted in loss of significant association to PE in both European Caucasian and primipara subgroups, and a number of other omissions (11, 18, 19) also affected the offspring association to PE (Table 6 ). One study changed the lack of genotype associations in the mothers (20) and no omissions changed the lack of association to PE for the father HLA-G 14bp I/D genotypes (Table 6 ). This meta-analysis should be interpreted within the context of its limitations. First, variable quality of the component studies was determined by the Newcastle-Ottawa Scale. Second, incompatible data disallowed examination of associations by disease severity, although data in the majority (73%) of the included studies were on severe PE (13, 15, (17) (18) (19) (20) (21) . Two studies (15, 20) presented genotypic data on severity of PE, but did not seem combinable because (a) Zhang et al´s (15) subjects were Han Chinese and data for individual family triad members were not presented, and (b)
Vianna et al's (20) subjects were Brazilian. Third, given the multiplicity of comparisons for different genetic models, race and primipara subgroups, with the unavoidable flexibility of choosing and defining the correlates, associations may have been detected by chance alone. Fourth, deviation of two studies (14, 15) from HWE may point to methodological weaknesses, such as biased selection of subjects, genotyping errors and population stratification (35) , and may have biased summary outputs.
However, this limitation was addressed with sensitivity analysis and the HWE-deviating studies did not alter any summary effects. Fifth, sensitivity treatment showed compromised robustness of the offspring subgroup effects. Finally, we have calculated that the actual sample size of each triad member used in the meta-analysis are large enough to detect an increased risk for preeclampsia at OR=1,363 for the mothers, and OR=1,412 for the offspring, but for the fathers the sample size was underpowered. The limitation that the father effects were underpowered was countered by the strengths of consistency and statistical homogeneity across the genetic models.
Despite these weaknesses, this meta-analysis has a number of strengths: First, the statistical homogeneity of pooled effects in mothers and fathers indicate comparability of the studies. Second, the lack of risk effects was consistent across the overall genetic models and triads. Third, controls were uniformly defined (i.e. healthy), as was the diagnosis of PE, thus minimizing non-differential misclassification bias. Lastly, we meta-analyzed data from each member of the family triad, which is a strength because PE development may involve father, mother and fetal genetic polymorphisms (36) .
The importance of our findings is underlined by the fact that the individual studies included in this meta-analysis did not have adequate statistical power, but when combined using the meta-analysis approach, a clear lack of association to PE for the HLA-G 14bp I/D polymorphism was revealed.
Likewise, associations with specific HLA-G alleles may exist which are due to linkage disequilibrium with other disease modifying alleles and are not reproduced in other populations (7) . For these reasons, subgroup analysis of geographically separate populations, as performed here, is a way to overcome population specific factors. This meta-analysis reports results that were not apparent from an examination of the individual studies. We find that meta-analysis is a useful tool in examining broad trends in genetic associations to disease, avoiding possible misleading conclusions based on small single-population studies.
In conclusion, this is to our knowledge the first meta-analysis that addresses association of the 
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Figure 2 Homozygous HLA-G 14bp I/D effects (II [+/+] vs DD [-/-]) among offspring. Diamond denotes the pooled odds ratio (OR)
. Squares indicate the OR in each study, with square sizes directly proportional to the weight contribution (%) of each study. Horizontal lines represent 95% confidence intervals (CI). The Z test for overall effect indicates significance if P < 0.05 and the chi-square test indicates heterogeneity thus using the random-effects model if P < 0.10, otherwise, the fixed-effects model was used. PB, Population-based; HB, Hospital-based; N, number of studies; O, Offspring; M, Mother; DNA, Deoxyribonucleic Acid; NOS, Newcastle-Ottawa Scale. 1 Triad means offspring, mother and father; 2 Vianna et al (20) supplied European-derived and Afro-derived mothers considered as two studies; 3 Humphrey et al (17) described controls as normotensive women; 3 Zhang et al (15) described controls as normal pregnancies; 4 Moreau (11) described controls as normal placentas 
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